Aeolus Pharmaceuticl Gross Profit vs. Price To Earning
| AOLS Stock | USD 0.0001 0.00 0.00% |
For Aeolus Pharmaceuticl profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aeolus Pharmaceuticl to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aeolus Pharmaceuticl utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aeolus Pharmaceuticl's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aeolus Pharmaceuticl over time as well as its relative position and ranking within its peers.
Aeolus |
Aeolus Pharmaceuticl Price To Earning vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aeolus Pharmaceuticl's current stock value. Our valuation model uses many indicators to compare Aeolus Pharmaceuticl value to that of its competitors to determine the firm's financial worth. Aeolus Pharmaceuticl is rated second in gross profit category among its peers. It also is rated second in price to earning category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aeolus Pharmaceuticl's earnings, one of the primary drivers of an investment's value.Aeolus Price To Earning vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Aeolus Pharmaceuticl |
| = | (805 K) |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Aeolus Pharmaceuticl |
| = | (2.37) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Aeolus Price To Earning Comparison
Aeolus Pharmaceuticl is currently under evaluation in price to earning category among its peers.
Aeolus Pharmaceuticl Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aeolus Pharmaceuticl, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aeolus Pharmaceuticl will eventually generate negative long term returns. The profitability progress is the general direction of Aeolus Pharmaceuticl's change in net profit over the period of time. It can combine multiple indicators of Aeolus Pharmaceuticl, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Aeolus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aeolus Pharmaceuticl. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aeolus Pharmaceuticl position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aeolus Pharmaceuticl's important profitability drivers and their relationship over time.
Use Aeolus Pharmaceuticl in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aeolus Pharmaceuticl position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aeolus Pharmaceuticl will appreciate offsetting losses from the drop in the long position's value.Aeolus Pharmaceuticl Pair Trading
Aeolus Pharmaceuticl Pair Trading Analysis
The ability to find closely correlated positions to Aeolus Pharmaceuticl could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aeolus Pharmaceuticl when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aeolus Pharmaceuticl - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aeolus Pharmaceuticl to buy it.
The correlation of Aeolus Pharmaceuticl is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aeolus Pharmaceuticl moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aeolus Pharmaceuticl moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aeolus Pharmaceuticl can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aeolus Pharmaceuticl position
In addition to having Aeolus Pharmaceuticl in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Penny Thematic Idea Now
Penny
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aeolus Pink Sheet Analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.